Patent · US Active

Peptide compound and application thereof, and composition containing peptide compound

US11807660B2 · kind B2 · utility

0Cited by

8References

8Claims

0Family size

Assignee

XDCEXPLORER (SHANGHAI) CO., LTD. · CN

Inventors

Yvonne Angell · Madison, US
Yu-Ling Wu · Tainan, TW
Yan Wang · San Diego, US
Weimin Liu · Sandy Hook, US
Kin Chiu Fong · Shanghai, CN
Jie Wen · Woodlawn, US
Yonghan Hu · Shanghai, CN

Key dates

Filing date	Mar 22, 2022
Grant date	Nov 7, 2023
Priority date	—
Expiry date	Mar 22, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are a peptide compound and an application thereof, and a composition containing the peptide compound. The present invention provides a peptide compound represented by compound 3, and a pharmaceutically acceptable salt, a tautomer, a solvate, a crystal form or a prodrug thereof. The compound has good stability and good activity for Kiss1R. Ac-(D-Tyr)-A6c-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH2

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.